LONDON BRIEFING: BP halts buybacks; AstraZeneca lifts annual earnings
(Alliance News) - BP suspends its share buyback programme as the oil major seeks to strengthen its balance sheet, while Barclays posts higher annual profit and earnings per share, and AstraZeneca lifts revenue and profit for 2025 while guiding for further growth in 2026. Read More